<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Supplementary Powders &#8211; BEHEMOTH LABZ</title>
	<atom:link href="https://behemothlabz.com/product-category/supplementary-powders/feed/" rel="self" type="application/rss+xml" />
	<link>https://behemothlabz.com</link>
	<description>For all your Laboratory research needs</description>
	<lastBuildDate>Mon, 05 Oct 2026 16:29:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://behemothlabz.com/wp-content/uploads/2024/11/cropped-favi-1-01-32x32.png</url>
	<title>Supplementary Powders &#8211; BEHEMOTH LABZ</title>
	<link>https://behemothlabz.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Synephrine HCl Powder</title>
		<link>https://behemothlabz.com/product/synephrine-hcl-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:40 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150671</guid>

					<description><![CDATA[Buy Synephrine HCl Powder Online Synephrine HCl is the hydrochloride salt form of synephrine, a sympathomimetic compound associated primarily with bitter orange (Citrus aurantium). It has been studied for metabolic activity, energy expenditure, exercise-related applications, and weight-management research. Product Information Most human research involving synephrine concerns p-synephrine, the principal protoalkaloid associated with bitter orange. Research [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy Synephrine HCl Powder Online</b></h2>
<p><span style="font-weight: 400;">Synephrine HCl is the hydrochloride salt form of synephrine, a sympathomimetic compound associated primarily with bitter orange (<i>Citrus aurantium</i>). It has been studied for metabolic activity, energy expenditure, exercise-related applications, and weight-management research.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Most human research involving synephrine concerns </span><b>p-synephrine</b><span style="font-weight: 400;">, the principal protoalkaloid associated with bitter orange. Research has examined its effects on resting metabolic rate, energy expenditure, cardiovascular parameters, and body composition.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">p-Synephrine interacts with adrenergic pathways involved in metabolic signaling and energy expenditure. Although structurally related to ephedrine, its pharmacological profile is different and should not be treated as interchangeable with ephedrine-type stimulants.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Supports Metabolic Activity</b></h3>
<p><span style="font-weight: 400;">Human studies have found that p-synephrine can increase resting metabolic rate and energy expenditure. This makes it particularly relevant to research into metabolism and weight management.</span></p>
<h3><b>2. Supports Energy Expenditure</b></h3>
<p><span style="font-weight: 400;">Synephrine has demonstrated measurable effects on energy expenditure in human research. The magnitude of the effect varies according to dose, formulation, and whether it is combined with other stimulants.</span></p>
<h3><b>3. Supports Weight-Management Research</b></h3>
<p><span style="font-weight: 400;">Synephrine-containing products have been investigated extensively for weight management. Evidence is mixed, however, and systematic review data have not established a significant long-term weight-loss effect.</span></p>
<h3><b>4. Exercise-Related Research Interest</b></h3>
<p><span style="font-weight: 400;">Synephrine has also been studied in sports and exercise settings because of its effects on metabolic activity and adrenergic signaling.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">Human studies have commonly investigated p-synephrine in the approximate range of </span><b>10-53 mg/day</b><span style="font-weight: 400;">, including studies lasting several weeks. These research amounts should not be interpreted as a universal recommended dose for Synephrine HCl products.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Potential concerns include increased blood pressure, increased heart rate, headache, nervousness, and cardiovascular stimulation. Combining synephrine with caffeine or other stimulants may increase cardiovascular stress.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Stohs SJ, Preuss HG, Shara M. <i>A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.</i> Int J Med Sci. 2012;9(7):527-538.</span><a href="https://pubmed.ncbi.nlm.nih.gov/22991491/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Stohs SJ, et al. <i>The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine: A Systematic Review and Meta-Analysis.</i></span><a href="https://pubmed.ncbi.nlm.nih.gov/36235672/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Bromantane Powder</title>
		<link>https://behemothlabz.com/product/bromantane-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:39 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150669</guid>

					<description><![CDATA[Buy Bromantane Powder Online Bromantane is an adamantane-derived actoprotector developed in Russia and investigated for its ability to support physical and mental performance under demanding conditions. It has also been studied for psychophysiological effects and fatigue resistance. Product Information Bromantane belongs to the actoprotector class, compounds designed to improve resistance to physical stress without simply [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy Bromantane Powder Online</b></h2>
<p><span style="font-weight: 400;">Bromantane is an adamantane-derived actoprotector developed in Russia and investigated for its ability to support physical and mental performance under demanding conditions. It has also been studied for psychophysiological effects and fatigue resistance.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Bromantane belongs to the actoprotector class, compounds designed to improve resistance to physical stress without simply producing conventional stimulant effects. Human and animal research has investigated its effects on functional performance, fatigue, and adaptation.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">Bromantane appears to influence several central and metabolic pathways involved in adaptation and performance. Its pharmacology is distinct from classic stimulants, with research suggesting effects on dopaminergic systems and adaptive responses to stress.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Supports Physical Performance</b></h3>
<p><span style="font-weight: 400;">Bromantane was developed as an actoprotector intended to improve physical work capacity and resistance to demanding conditions. Research has investigated its effects during fatigue, heat, hypoxia, and other physical stressors.</span></p>
<h3><b>2. Supports Fatigue Resistance</b></h3>
<p><span style="font-weight: 400;">One of Bromantane's defining research characteristics is its ability to improve performance under conditions associated with fatigue. Animal studies have demonstrated increased working capacity and improved recovery from experimentally induced fatigue.</span></p>
<h3><b>3. Mental Performance Research</b></h3>
<p><span style="font-weight: 400;">Human research has examined Bromantane's influence on EEG and psychophysiological performance, including studies in healthy volunteers showing favorable effects on functional state.</span></p>
<h3><b>4. Adaptation to Environmental Stress</b></h3>
<p><span style="font-weight: 400;">Bromantane has been studied under challenging environmental conditions such as heat and hypoxia. Historical human research reported improved resistance to combined environmental stressors following oral administration.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">Historical human research has included </span><b>250 mg orally</b><span style="font-weight: 400;"> in healthy volunteers and in environmental-stress experiments. These are study-specific historical doses rather than a modern standardized therapeutic regimen.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Potential effects may include stimulation, insomnia, headache, changes in mood, gastrointestinal symptoms, or alterations in blood pressure and heart rate. Long-term safety information outside historical clinical use is limited.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Kim H, et al. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. <i>Pharmacol Ther</i>. 2013. PMID: 24009833.</span><a href="https://pubmed.ncbi.nlm.nih.gov/24009833/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Viatleva OA, et al. The neuro- and psychophysiological effects of bromantane. <i>Voen Med Zh</i>. 2000. PMID: 10998997.</span><a href="https://pubmed.ncbi.nlm.nih.gov/10998997/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Sedov AV, et al. Experimental rationale for the use of drugs to increase the resistance of the human body to the combined action of carbon monoxide and hyperthermia. <i>Med Tr Prom Ekol</i>. 1993. PMID: 8087458.</span><a href="https://pubmed.ncbi.nlm.nih.gov/8087458/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NAD+ Powder</title>
		<link>https://behemothlabz.com/product/nad-plus-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:39 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150670</guid>

					<description><![CDATA[Buy NAD+ Powder Online NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring coenzyme involved in cellular energy production, redox reactions, DNA repair, and metabolic signaling. NAD+ has become an important area of research surrounding cellular health, aging, mitochondrial function, and metabolic resilience. Product Information NAD+ is the oxidized form of nicotinamide adenine dinucleotide and is [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy NAD+ Powder Online</b></h2>
<p><span style="font-weight: 400;">NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring coenzyme involved in cellular energy production, redox reactions, DNA repair, and metabolic signaling. NAD+ has become an important area of research surrounding cellular health, aging, mitochondrial function, and metabolic resilience.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">NAD+ is the oxidized form of nicotinamide adenine dinucleotide and is present throughout the body's cells. It participates in mitochondrial energy production and serves as a substrate for enzymes including sirtuins and PARPs. Direct NAD+ administration has been studied in humans, although the clinical evidence remains considerably smaller than the broader literature on NAD+ precursors such as nicotinamide riboside and NMN.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">NAD+ helps cells transfer energy during metabolic reactions and supports enzymes involved in cellular maintenance and stress responses. Its availability can influence mitochondrial metabolism, DNA-repair pathways, and cellular signaling.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Supports Cellular Energy Production</b></h3>
<p><span style="font-weight: 400;">NAD+ is central to mitochondrial energy metabolism and helps cells convert nutrients into usable energy. Maintaining NAD+ availability is therefore closely tied to normal cellular energy production.</span></p>
<h3><b>2. Supports Healthy Aging Research</b></h3>
<p><span style="font-weight: 400;">NAD+ participates in DNA repair, cellular stress responses, and sirtuin signaling. These roles have made NAD+ one of the most closely studied molecules in modern longevity and healthy-aging research.</span></p>
<h3><b>3. Supports Metabolic Function</b></h3>
<p><span style="font-weight: 400;">NAD+-dependent enzymes contribute to glucose, fatty-acid, and mitochondrial metabolism. Researchers continue to investigate whether maintaining NAD+ availability can support metabolic resilience as people age.</span></p>
<h3><b>4. Supports Cellular Maintenance</b></h3>
<p><span style="font-weight: 400;">NAD+ serves as a substrate for enzymes involved in DNA-damage responses and other cellular maintenance processes. This has made NAD+ particularly interesting in research on age-related cellular decline.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">There is no universally established clinical dosage for direct NAD+ supplementation for general wellness or longevity. A human pilot study examined a continuous IV infusion at </span><b>3 umol/min for six hours</b><span style="font-weight: 400;">, demonstrating rapid metabolism of infused NAD+. This was a pharmacokinetic research study rather than an established general supplementation regimen.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Human safety data for direct NAD+ administration remain limited. Infusion-related symptoms have been reported in clinical practice, and direct IV administration should be performed only within an appropriate medical setting.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Grant R, et al. <i>A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD.</i> Front Aging Neurosci. 2019;11:257.</span><a href="https://pubmed.ncbi.nlm.nih.gov/31572171/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Noopept (Omberacetam) Powder</title>
		<link>https://behemothlabz.com/product/noopept-omberacetam-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:38 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150668</guid>

					<description><![CDATA[Buy Noopept (Omberacetam) Powder Online Noopept, also known as Omberacetam or GVS-111, is a synthetic proline-containing dipeptide ester developed as a potent nootropic compound. It has been investigated for memory, cognitive impairment, neuroprotection, and adaptation to physical stress. Product Information Noopept has been studied in Russian clinical literature as a cognitive and neuroprotective agent. Human [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy Noopept (Omberacetam) Powder Online</b></h2>
<p><span style="font-weight: 400;">Noopept, also known as Omberacetam or GVS-111, is a synthetic proline-containing dipeptide ester developed as a potent nootropic compound. It has been investigated for memory, cognitive impairment, neuroprotection, and adaptation to physical stress.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Noopept has been studied in Russian clinical literature as a cognitive and neuroprotective agent. Human studies have used 10-20 mg/day, while preclinical research has explored mechanisms involving neurotrophic signaling, oxidative stress, inflammation, and glutamate-related neurotoxicity.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">Noopept appears to influence multiple neuronal pathways rather than acting through a single receptor. Research has associated it with neurotrophic signaling, antioxidant activity, modulation of glutamate-related toxicity, and effects on memory consolidation and retrieval.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Supports Memory Research</b></h3>
<p><span style="font-weight: 400;">Noopept has been investigated for memory acquisition, consolidation, and retrieval. Human clinical research has reported improvements in selected cognitive measures in people with cognitive impairment.</span></p>
<h3><b>2. Neuroprotective Research</b></h3>
<p><span style="font-weight: 400;">Preclinical research has reported protection against ischemic and excitotoxic neuronal damage. These findings have contributed to Noopept's reputation as a neuroprotective as well as nootropic compound.</span></p>
<h3><b>3. Cognitive-Function Support</b></h3>
<p><span style="font-weight: 400;">Clinical studies have examined Noopept in patients with cognitive impairment associated with stroke, vascular disease, and trauma. A published study used 20 mg/day for two months and reported improved cognitive measures.</span></p>
<h3><b>4. Anxiolytic and Adaptogenic Research</b></h3>
<p><span style="font-weight: 400;">Noopept has also been investigated for anxiety-related effects and adaptation to environmental stress. Human volunteer research reported effects on psychological and physical performance under challenging environmental conditions.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">Published human studies have used </span><b>10 mg twice daily (20 mg/day)</b><span style="font-weight: 400;">, including a clinical study involving patients with stroke-related cognitive impairment. Earlier clinical-development literature also describes 5 mg and 10 mg tablet strengths. These doses reflect historical clinical research rather than a recommendation for unsupervised use.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Reported clinical studies suggest relatively good short-term tolerability, but possible headache, irritability, sleep changes, gastrointestinal effects, or other CNS symptoms may occur. Long-term safety data remain limited, especially outside the populations studied clinically.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Gudasheva TA, et al. The original novel nootropic and neuroprotective agent noopept. <i>Eksperimental'naia i klinicheskaia farmakologiia</i>. 2002. PMID: 12596521.</span><a href="https://pubmed.ncbi.nlm.nih.gov/12596521/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Amelin AV, Iliukhina AIu, Shmonin AA. Noopept in the treatment of mild cognitive impairment in patients with stroke. <i>Zh Nevrol Psikhiatr Im S S Korsakova</i>. 2011;111(10 Pt 1):44-46. PMID: 22500312.</span><a href="https://pubmed.ncbi.nlm.nih.gov/22500312/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Shabanov PD, Ganapol'skii VP, Aleksandrov PV. Meteoadaptogenic properties of peptide drugs in healthy volunteers. <i>Eksperimental'naia i klinicheskaia farmakologiia</i>. 2007;70(6):41-47. PMID: 18318195.</span><a href="https://pubmed.ncbi.nlm.nih.gov/18318195/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Szeleszczuk L, et al. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept). 2024. PMID: 39298839.</span><a href="https://pubmed.ncbi.nlm.nih.gov/39298839/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NSI-189 Free Base Powder</title>
		<link>https://behemothlabz.com/product/nsi-189-free-base-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:37 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150667</guid>

					<description><![CDATA[Buy NSI-189 Free Base Powder Online NSI-189 Free Base is the non-phosphate form of NSI-189, a small-molecule compound developed to investigate neurogenesis and hippocampal function. The active NSI-189 molecule is the basis of the clinical research conducted with its phosphate salt. Product Information The clinical development of NSI-189 primarily used NSI-189 phosphate, including Phase 1B [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy NSI-189 Free Base Powder Online</b></h2>
<p><span style="font-weight: 400;">NSI-189 Free Base is the non-phosphate form of NSI-189, a small-molecule compound developed to investigate neurogenesis and hippocampal function. The active NSI-189 molecule is the basis of the clinical research conducted with its phosphate salt.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">The clinical development of NSI-189 primarily used </span><b>NSI-189 phosphate</b><span style="font-weight: 400;">, including Phase 1B and Phase 2 randomized trials. The free-base form represents the same active molecular entity without the phosphate salt, but its pharmacokinetic and formulation characteristics should not automatically be assumed identical.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">NSI-189 was developed as a neurogenic compound intended to influence neuronal growth and hippocampal function. Unlike traditional antidepressants, its proposed activity does not center on direct monoamine reuptake inhibition.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Neurogenesis Research</b></h3>
<p><span style="font-weight: 400;">NSI-189 is particularly notable for its focus on neurogenesis and hippocampal biology. This mechanism has made it an important research compound for investigating how neuronal growth may influence cognition and mood.</span></p>
<h3><b>2. Cognitive Research</b></h3>
<p><span style="font-weight: 400;">Clinical trials included cognitive and physical-functioning assessments, with some exploratory improvements observed during early development.</span></p>
<h3><b>3. Mood-Related Research</b></h3>
<p><span style="font-weight: 400;">NSI-189 was investigated in patients with major depressive disorder. Although Phase 2 results did not establish superiority on the primary depression endpoint, some secondary outcomes showed potential activity.</span></p>
<h3><b>4. Hippocampal Function</b></h3>
<p><span style="font-weight: 400;">The compound's development was based in part on the relationship between hippocampal neurogenesis and cognitive and emotional function, giving NSI-189 a distinctive neuroscience research profile.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">Published human trials used </span><b>NSI-189 phosphate</b><span style="font-weight: 400;">, not a separately validated free-base dosing protocol. Phase 2 studies tested 40 and 80 mg/day of the phosphate form. These doses should not automatically be treated as equivalent dosing for a free-base formulation.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">The human safety profile is limited to clinical development of NSI-189 phosphate. Potential CNS and systemic adverse effects remain incompletely characterized for separately formulated free-base material.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Fava M, et al. A Phase 1B, randomized, double blind, placebo-controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. <i>Mol Psychiatry</i>. 2016;21(10):1372-1380. PMID: 26643541.</span><a href="https://pubmed.ncbi.nlm.nih.gov/26643541/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Papakostas GI, et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. <i>Mol Psychiatry</i>. 2020;25(7):1569-1579. PMID: 30626911.</span><a href="https://pubmed.ncbi.nlm.nih.gov/30626911/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NSI-189 Phosphate Powder</title>
		<link>https://behemothlabz.com/product/nsi-189-phosphate-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:36 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150666</guid>

					<description><![CDATA[Buy NSI-189 Phosphate Powder Online NSI-189 Phosphate is a small-molecule neurogenic compound developed to investigate hippocampal neurogenesis and cognitive and mood-related disorders. It progressed through human clinical trials in major depressive disorder. Product Information NSI-189 was evaluated in randomized controlled clinical studies using oral doses of 40 and 80 mg/day. Phase 1B research suggested potential [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy NSI-189 Phosphate Powder Online</b></h2>
<p><span style="font-weight: 400;">NSI-189 Phosphate is a small-molecule neurogenic compound developed to investigate hippocampal neurogenesis and cognitive and mood-related disorders. It progressed through human clinical trials in major depressive disorder.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">NSI-189 was evaluated in randomized controlled clinical studies using oral doses of 40 and 80 mg/day. Phase 1B research suggested potential effects on depressive and cognitive measures, while the subsequent Phase 2 trial did not significantly improve its primary depression endpoint.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">NSI-189 was designed to influence neurogenesis, particularly within the hippocampus. Its mechanism differs from traditional antidepressants because it does not primarily depend on monoamine reuptake inhibition.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Neurogenesis Research</b></h3>
<p><span style="font-weight: 400;">NSI-189 was developed specifically around the concept of stimulating neuronal growth and hippocampal neurogenesis, making it a distinctive compound in neuroscience research.</span></p>
<h3><b>2. Cognitive Function Research</b></h3>
<p><span style="font-weight: 400;">Human studies included cognitive and physical-functioning assessments, with Phase 1B research reporting exploratory improvements in selected cognitive measures.</span></p>
<h3><b>3. Mood Research</b></h3>
<p><span style="font-weight: 400;">NSI-189 progressed into clinical trials for major depressive disorder. Although the primary Phase 2 depression endpoint was not statistically significant, several secondary measures showed signals of potential activity.</span></p>
<h3><b>4. Non-Monoaminergic Approach</b></h3>
<p><span style="font-weight: 400;">NSI-189's proposed neurogenic mechanism differentiates it from conventional antidepressants that primarily target serotonin, norepinephrine, or dopamine reuptake.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">Human Phase 1B research evaluated </span><b>40 mg once daily, 40 mg twice daily, and 40 mg three times daily</b><span style="font-weight: 400;">. A later Phase 2 trial evaluated </span><b>40 mg/day and 80 mg/day for 12 weeks</b><span style="font-weight: 400;">. These are clinical-trial doses rather than an established current treatment regimen.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Clinical trials reported generally acceptable short-term tolerability, although adverse events occurred. Because NSI-189 has not become an established mainstream therapy, long-term safety and broader drug-interaction data remain limited.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Fava M, et al. A Phase 1B, randomized, double blind, placebo-controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. <i>Mol Psychiatry</i>. 2016;21(10):1372-1380. PMID: 26643541.</span><a href="https://pubmed.ncbi.nlm.nih.gov/26643541/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Papakostas GI, et al. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. <i>Mol Psychiatry</i>. 2020;25(7):1569-1579. PMID: 30626911.</span><a href="https://pubmed.ncbi.nlm.nih.gov/30626911/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>RU58841 Powder</title>
		<link>https://behemothlabz.com/product/ru58841-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:35 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150664</guid>

					<description><![CDATA[Buy RU58841 Powder Online RU58841 is a nonsteroidal antiandrogen developed for topical inhibition of androgen-receptor activity. It has attracted considerable research interest in androgen-dependent skin and hair conditions, particularly androgenetic alopecia. Product Information RU58841 competes with androgens at the androgen receptor. Experimental research has demonstrated suppression of androgen-dependent signaling in human prostate cells and activity [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy RU58841 Powder Online</b></h2>
<p><span style="font-weight: 400;">RU58841 is a nonsteroidal antiandrogen developed for topical inhibition of androgen-receptor activity. It has attracted considerable research interest in androgen-dependent skin and hair conditions, particularly androgenetic alopecia.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">RU58841 competes with androgens at the androgen receptor. Experimental research has demonstrated suppression of androgen-dependent signaling in human prostate cells and activity against hair-growth effects in animal models.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">RU58841 acts as an androgen-receptor antagonist, reducing the ability of testosterone-derived androgens such as DHT to activate the receptor. Its intended research application has primarily involved local rather than systemic androgen blockade.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Androgen-Receptor Research</b></h3>
<p><span style="font-weight: 400;">RU58841 directly targets androgen-receptor signaling, making it a useful research compound for understanding how androgen activity affects skin, hair follicles, and other androgen-responsive tissues.</span></p>
<h3><b>2. Hair-Loss Research</b></h3>
<p><span style="font-weight: 400;">Animal studies have investigated RU58841 as a topical antiandrogen for androgen-dependent hair loss. Its local receptor activity is the principal reason it has become associated with hair-regrowth research.</span></p>
<h3><b>3. DHT-Signaling Modulation</b></h3>
<p><span style="font-weight: 400;">Rather than reducing testosterone production directly, RU58841 works downstream by interfering with androgen-receptor activation. This provides a mechanistically distinct approach to androgen signaling.</span></p>
<h3><b>4. Nonsteroidal Antiandrogen</b></h3>
<p><span style="font-weight: 400;">RU58841 is structurally distinct from steroidal antiandrogens. Laboratory studies demonstrated competitive suppression of DHT-driven androgen-receptor activation.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">There is </span><b>no established human therapeutic dosage</b><span style="font-weight: 400;"> for RU58841. Historical research has focused primarily on topical experimental administration, including animal models. Online dosing practices should not be presented as clinically validated human dosing.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Human safety data are inadequate. Potential concerns include local irritation and unpredictable systemic antiandrogenic effects if absorption occurs. The long-term safety of unsupervised topical use has not been established.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Sintov A, et al. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stump-tailed macaques. <i>Endocrine</i>. 1998;9(1):39-43. PMID: 9798729.</span><a href="https://pubmed.ncbi.nlm.nih.gov/9798729/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Miyamoto H, et al. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. <i>Proc Natl Acad Sci USA</i>. 1998;95(13):7379-7384. PMID: 9636157.</span><a href="https://pubmed.ncbi.nlm.nih.gov/9636157/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dihexa Powder</title>
		<link>https://behemothlabz.com/product/dihexa-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:35 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150665</guid>

					<description><![CDATA[Buy Dihexa Powder Online Dihexa is a small-molecule analog derived from angiotensin IV research and developed as a blood-brain-barrier-penetrant HGF/c-Met pathway modulator. It has attracted substantial interest because of its reported effects on synaptic formation and cognitive performance in animal models. Product Information Research has shown that Dihexa binds hepatocyte growth factor (HGF), enhances HGF-dependent [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy Dihexa Powder Online</b></h2>
<p><span style="font-weight: 400;">Dihexa is a small-molecule analog derived from angiotensin IV research and developed as a blood-brain-barrier-penetrant HGF/c-Met pathway modulator. It has attracted substantial interest because of its reported effects on synaptic formation and cognitive performance in animal models.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Research has shown that Dihexa binds hepatocyte growth factor (HGF), enhances HGF-dependent c-Met signaling, and promotes hippocampal spinogenesis and synaptogenesis. Oral Dihexa has also demonstrated procognitive effects in animal models.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">Dihexa interacts with HGF and enhances signaling through the c-Met receptor. This pathway is involved in neuronal growth, synaptic development, and cellular repair, providing the mechanistic basis for Dihexa's cognitive research profile.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Synaptogenesis Research</b></h3>
<p><span style="font-weight: 400;">Dihexa has demonstrated the ability to promote hippocampal spinogenesis and synaptogenesis in experimental systems. These effects make it particularly interesting in research focused on forming and strengthening neuronal connections.</span></p>
<h3><b>2. Cognitive Performance Research</b></h3>
<p><span style="font-weight: 400;">Orally administered Dihexa has produced procognitive effects in animal models, including improvements in spatial-learning tasks. This is one of the compound's most notable research characteristics.</span></p>
<h3><b>3. Neuroplasticity Research</b></h3>
<p><span style="font-weight: 400;">By influencing HGF/c-Met signaling, Dihexa may affect pathways involved in neuronal growth and structural plasticity. This gives it a broader research profile than compounds acting solely as acute stimulants.</span></p>
<h3><b>4. Blood-Brain-Barrier Penetration</b></h3>
<p><span style="font-weight: 400;">Dihexa was specifically developed to overcome the blood-brain-barrier limitations associated with earlier angiotensin-derived molecules, allowing it to reach central nervous system targets in experimental models.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">There is </span><b>no established human dosage for Dihexa</b><span style="font-weight: 400;">. Research doses in animal and cellular models should not be interpreted as human therapeutic dosing.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Human safety data are very limited. Because HGF/c-Met signaling regulates growth, differentiation, and tissue remodeling, unintended effects from sustained pathway activation remain an important research concern.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">McCoy AT, et al. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. <i>J Pharmacol Exp Ther</i>. 2014;349(2):286-293. PMID: 25187433.</span><a href="https://pubmed.ncbi.nlm.nih.gov/25187433/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Mizuno S, Nakamura T. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. <i>Front Pharmacol</i>. 2015. PMID: 25649658.</span><a href="https://pubmed.ncbi.nlm.nih.gov/25649658/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>7,8-Dihydroxyflavone Powder</title>
		<link>https://behemothlabz.com/product/7-8-dihydroxyflavone-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:34 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150663</guid>

					<description><![CDATA[Buy 7,8-Dihydroxyflavone Powder Online 7,8-Dihydroxyflavone (7,8-DHF) is a flavone derivative best known for its activity at the TrkB receptor, the principal receptor for brain-derived neurotrophic factor (BDNF). It has become a prominent research compound in neuroscience and neuroprotection. Product Information Preclinical research has shown that 7,8-DHF can activate TrkB and downstream signaling pathways associated with [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy 7,8-Dihydroxyflavone Powder Online</b></h2>
<p><span style="font-weight: 400;">7,8-Dihydroxyflavone (7,8-DHF) is a flavone derivative best known for its activity at the TrkB receptor, the principal receptor for brain-derived neurotrophic factor (BDNF). It has become a prominent research compound in neuroscience and neuroprotection.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Preclinical research has shown that 7,8-DHF can activate TrkB and downstream signaling pathways associated with neuronal survival, differentiation, and synaptic plasticity. Studies have examined its effects in models of neurodegeneration, stroke, Parkinsonism, and cognitive dysfunction.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">7,8-DHF binds to and activates TrkB, mimicking certain signaling effects normally produced by BDNF. TrkB activation can influence neuronal survival, synaptic plasticity, and neurotrophic signaling.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Supports Neurotrophic Signaling</b></h3>
<p><span style="font-weight: 400;">7,8-DHF directly activates TrkB-related signaling, making it particularly interesting for research into BDNF-associated neuronal function.</span></p>
<h3><b>2. Memory and Cognitive Research</b></h3>
<p><span style="font-weight: 400;">Animal studies have reported improvements in memory-related behavior following 7,8-DHF administration, supporting its investigation as a potential cognitive research tool.</span></p>
<h3><b>3. Neuroprotective Potential</b></h3>
<p><span style="font-weight: 400;">7,8-DHF has protected neurons in several experimental models, including models involving excitotoxicity, ischemic injury, and dopaminergic degeneration.</span></p>
<h3><b>4. Synaptic Plasticity Research</b></h3>
<p><span style="font-weight: 400;">TrkB activation is closely associated with synaptic remodeling and plasticity. Research has demonstrated that 7,8-DHF can promote signaling linked to synaptogenesis and neuronal maturation.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">There is </span><b>no established human therapeutic dosage</b><span style="font-weight: 400;"> for 7,8-DHF. Published doses are primarily from cellular and animal experiments and should not be treated as validated human dosing.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Human safety data are limited. Because TrkB signaling influences numerous neuronal and cellular processes, the consequences of sustained pharmacological activation remain incompletely characterized.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Liu X, et al. Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor. <i>J Biol Chem</i>. 2014;289(40):27571-27584. PMID: 25143381.</span><a href="https://pubmed.ncbi.nlm.nih.gov/25143381/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Jang SW, et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. <i>Proc Natl Acad Sci USA</i>. 2010;107(6):2687-2692. PMID: 20133810.</span><a href="https://pubmed.ncbi.nlm.nih.gov/20133810/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Liu C et al. 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neuron degeneration through activation of TrkB in rodents. <i>Neurosci Lett</i>. 2016. PMID: 27019033.</span><a href="https://pubmed.ncbi.nlm.nih.gov/27019033/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Amentoflavone (20% Extract) Powder</title>
		<link>https://behemothlabz.com/product/amentoflavone-20-extract-powder/</link>
		
		<dc:creator><![CDATA[Zeeshan Tariq]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 16:12:33 +0000</pubDate>
				<guid isPermaLink="false">https://behemothlabz.com/?post_type=product&#038;p=150662</guid>

					<description><![CDATA[Buy Amentoflavone (20% Extract) Powder Online Amentoflavone is a naturally occurring biflavonoid found in several medicinal plants, including Selaginella species. A standardized 20% extract provides a concentrated source of Amentoflavone for nutritional and research applications. Product Information Amentoflavone has been extensively investigated for antioxidant, anti-inflammatory, metabolic, neurological, and cellular effects. Despite its broad preclinical profile, [...]]]></description>
										<content:encoded><![CDATA[<h2><b>Buy Amentoflavone (20% Extract) Powder Online</b></h2>
<p><span style="font-weight: 400;">Amentoflavone is a naturally occurring biflavonoid found in several medicinal plants, including <i>Selaginella</i> species. A standardized 20% extract provides a concentrated source of Amentoflavone for nutritional and research applications.</span></p>
<h2><b>Product Information</b></h2>
<p><span style="font-weight: 400;">Amentoflavone has been extensively investigated for antioxidant, anti-inflammatory, metabolic, neurological, and cellular effects. Despite its broad preclinical profile, poor water solubility and limited bioavailability have restricted its development as a conventional therapeutic drug.</span></p>
<h2><b>How It Works</b></h2>
<p><span style="font-weight: 400;">Amentoflavone influences multiple molecular pathways, including inflammatory signaling, oxidative-stress pathways, and cellular kinase systems. It is therefore considered a multi-target flavonoid rather than a compound acting through a single receptor.</span></p>
<h2><b>POTENTIAL BENEFITS</b></h2>
<h3><b>1. Antioxidant Activity</b></h3>
<p><span style="font-weight: 400;">Amentoflavone has demonstrated significant antioxidant activity in laboratory research, making it relevant to studies involving oxidative stress and cellular protection.</span></p>
<h3><b>2. Anti-Inflammatory Research</b></h3>
<p><span style="font-weight: 400;">Research has identified effects on inflammatory pathways, including NF-kB and related signaling networks. This broad activity has contributed to substantial interest in Amentoflavone research.</span></p>
<h3><b>3. Neuroprotective Research</b></h3>
<p><span style="font-weight: 400;">Amentoflavone has been investigated in neurological models involving oxidative stress, inflammation, neuronal signaling, and cellular survival, creating a broad neuroprotective research profile.</span></p>
<h3><b>4. Metabolic Research</b></h3>
<p><span style="font-weight: 400;">Experimental research has examined Amentoflavone in relation to glucose and lipid metabolism, including pathways relevant to metabolic dysfunction and healthy aging.</span></p>
<h2><b>Dosage</b></h2>
<p><span style="font-weight: 400;">There is </span><b>no established human therapeutic dosage for Amentoflavone</b><span style="font-weight: 400;">. A 20% extract is formulation-specific, so the actual Amentoflavone content depends on the total extract quantity. Human dosing should not be inferred from animal studies.</span></p>
<h2><b>Side Effects</b></h2>
<p><span style="font-weight: 400;">Human safety data are limited. Amentoflavone also has demonstrated the ability to inhibit several drug-metabolizing enzymes in laboratory studies, creating potential drug-interaction concerns.</span></p>
<h3><b>References</b></h3>
<ol>
<li style="font-weight: 400;"><span style="font-weight: 400;">Yu S, Yan H, Zhang L, et al. A Review on the Phytochemistry, Pharmacology, and Pharmacokinetics of Amentoflavone, a Naturally-Occurring Biflavonoid. <i>Molecules</i>. 2017;22(2):299. PMID: 28212342.</span><a href="https://pubmed.ncbi.nlm.nih.gov/28212342/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Zhang X, et al. Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. <i>Front Pharmacol</i>. 2022. PMID: 35002708.</span><a href="https://pubmed.ncbi.nlm.nih.gov/35002708/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
<li style="font-weight: 400;"><span style="font-weight: 400;">Wang Y, et al. Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders. <i>Front Pharmacol</i>. 2024. PMID: 39624841.</span><a href="https://pubmed.ncbi.nlm.nih.gov/39624841/" target="_blank" rel="nofollow noopener"> <span style="font-weight: 400;">PubMed</span></a></li>
</ol>
<p><b>Note:</b><span style="font-weight: 400;"> BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.</span></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
